HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
27277studies shown
Showing 2,785-2,796 of 27,277
Drug study icon
RecruitingNCT05980949

Safety study of KarXT in Schizophrenia

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 55–90
Countries
United States, France, Canada, + 27 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingEUCTR 2022-001582-12

Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode.

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Barcelona
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Consorcio Centro de Investigacion Biomedica en Red (CIBER)
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.